While recent studies have shown that patients with severe COVID-19 tend to have lower levels of interferon-gamma (IFN-γ) compared to those with milder forms of the disease (29, 30), in our analysis IFN-γ shows a moderate (non-significant) increase with disease severity. This evidence concerns the gene IFNG and COVID-19.